Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples